The company faces a number of uncertainties and risks that are difficult to predict and many of which are outside of the company's control. If known or unknown risks or uncertainties materialize, the company's business, results of operations or financial condition could be adversely affected, potentially in a material way. The company has experienced significant challenges to patents covering its largest product, which could lead to a reduction in sales. Global sales in the company's pharmaceutical and medical devices segments may be negatively impacted by healthcare reforms and increasing pricing pressures. The company is subject to numerous claims and lawsuits involving various issues such as patent disputes and product liability, which could have a material adverse effect on the company's results of operations and cash flows. Product reliability, safety, and effectiveness concerns can lead to litigation and cause reputational damage. Changes in tax laws or exposures to additional tax liabilities could negatively impact the company's operating results. The company regularly assesses the likely outcomes of its tax audits to determine the appropriateness of its tax reserves. The company may not be able to successfully secure and defend intellectual property rights essential to its businesses, which are materially important to the company's results of operations. The company faces substantial competition in all operating segments and geographic markets, which could adversely affect the company's earnings. The company’s continued growth and success depend on its ability to innovate and develop new and differentiated products and services that address the evolving health care needs of patients, providers, and consumers. Development of successful products and technologies is necessary to offset revenue losses when existing products lose market share due to various factors such as competition and loss of patent exclusivity. The company strives to maintain a purpose-driven organization and is committed to developing global business leaders who can achieve growth objectives. The company believes that its strategic framework and long-term growth drivers, along with its overall mission of improving the quality of life for people around the world, will enable it to continue to be a leader in the health care industry. The company is exposed to fluctuations in currency exchange rates and inflation rates, which can impact profitability. The company continues to monitor economic conditions and take appropriate actions to maintain its profit margins through cost reduction programs and productivity improvements. The company has faced unanticipated interruptions and delays in manufacturing, which can result in product shortages and declines in sales. An information security incident, including a cybersecurity breach, could negatively impact the company's business or reputation. The company continually assesses these threats and makes investments to increase internal protection, detection, and response capabilities. The company’s businesses operate in highly competitive product markets, and competitive pressures could adversely affect the company's earnings. The company is committed to creating value by developing accessible, high-quality, innovative products and services. The company manages within a strategic framework with a decentralized management approach, which positions it well to innovate, execute strategic plans, and address local market challenges. The company believes that maintaining operational flexibility and adaptability is crucial for sustaining market leadership positions and enabling growth.